New

Mamotest

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

AI Digital solution transforming care delivery by democratizing access to screening & diagnosis while providing efficient path to treatment.

HQ Location

Mexico

Founded

2013

Employees

11 - 50

Total funding raised

Not available

Last Funding Event

Not available

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M

Operator of a health tech company intended to save lives by democratizing access to breast cancer screening and treatment globally. The company offers an end-to-end solution, combining advanced AI technology, teleradiology services, and partnerships with local healthcare providers to ensure early and accurate detection of breast cancer by connecting patients, healthcare centers, and experienced radiologists, creating a seamless diagnostic process, improving access to high-quality care, It leverages a proprietary platform to assist mammogram analysis and enhance diagnostic accuracy, Its solution aims to streamline patient care by enabling remote diagnoses, empowering local centers, and raising awareness of early detection through targeted campaigns and a navigation program to guide women through the journey.